SCHEMBL974515

SCHEMBL974515

CC(C)N(C)S(=O)(=O)NC(=O)c1cc(N=C=O)c(F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 18/20 0.43
POLB P06746 1/20 0.39
APEX1 P27695 1/20 0.39
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL713577 0.80 SCN9A (0.46) SCN9APOLBAPEX1CYP2C19
SCHEMBL977040 0.79 SCN9A (0.34) SCN9APOLBAPEX1CYP2C19
SCHEMBL31118371 0.78 SCN9A (0.45) SCN9APOLBAPEX1CYP2C19
SCHEMBL3544332 0.77 POLB (0.33) SCN9APOLBAPEX1CYP2C19
SCHEMBL3540540 0.77 POLB (0.34) SCN9APOLBAPEX1CYP2C19
SCHEMBL3059734 0.76 SCN9A (0.43) SCN9APOLBAPEX1CYP2C19
SCHEMBL25046395 0.76 SCN9A (0.42) SCN9APOLBAPEX1CYP2C19
SCHEMBL25047105 0.75 SCN9A (0.43) SCN9APOLBAPEX1CYP2C19
SCHEMBL712255 0.75 SCN9A (0.45) SCN9ACYP2C19
SCHEMBL972982 0.73 HPGD (0.44) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541611-B2 Bifunctional phenyl iso(thio)cyanates, processes and intermediates products for their preparation BASF AKTIENGESELLSCHAFT (DE) 2013-09-24 US disclosed
US-8541611-B2 Bifunctional phenyl iso(thio)cyanates, processes and intermediates products for their preparation BASF AKTIENGESELLSCHAFT (DE) 2013-09-24 US disclosed
US-8357695-B2 Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide BASF SE (DE) 2013-01-22 US disclosed
EP-2537829-A1 Aminobenzoylsulfamides and their preparation BASF SE (DE) 2012-12-26 EP disclosed
US-20120271049-A1 BIFUNCTIONAL PHENYL ISO (THIO) CYANATES, PROCESSES AND INTERMEDIATES PRODUCTS FOR THEIR PREPARATION BASF AKTIENGESELLSCHAFT (DE) 2012-10-25 US disclosed
US-20120271049-A1 BIFUNCTIONAL PHENYL ISO (THIO) CYANATES, PROCESSES AND INTERMEDIATES PRODUCTS FOR THEIR PREPARATION BASF AKTIENGESELLSCHAFT (DE) 2012-10-25 US disclosed
EP-2079714-B1 HYDRATES OF 2-CHLORO-5-Ý3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUORO-METHYL)-1-(2H)-PYRIMIDINYL¨-4-FLUORO-N-ÝÝMETHYL-(1-METHYLETHYL)-AMINO¨SULPHONYL¨BENZAMIDE BASF SE (DE) 2012-09-26 EP disclosed
EP-1560810-B1 BIFUNCTIONAL PHENYLISO(THIO)CYANATES; METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF BASF SE (DE) 2012-08-01 EP disclosed
US-8232421-B2 Bifunctional phenyl ISO (THIO) cyanates, processes and intermediates for their preparation BASF AKTIENGESELLSCHAFT (DE) 2012-07-31 US disclosed
US-8232421-B2 Bifunctional phenyl ISO (THIO) cyanates, processes and intermediates for their preparation BASF AKTIENGESELLSCHAFT (DE) 2012-07-31 US disclosed
US-20100035905-A1 Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide BASF Agro B.V. (CH) 2010-02-11 US disclosed
EP-2079714-A1 HYDRATES OF 2-CHLORO-5-Ý3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUORO-METHYL)-1-(2H)-PYRIMIDINYL¨-4-FLUORO-N-ÝÝMETHYL-(1-METHYLETHYL)-AMINO¨SULPHONYL¨BENZAMIDE BASF SE (DE) 2009-07-22 EP disclosed
WO-2008043836-A1 HYDRATES OF 2-CHLORO-5-[3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUORO-METHYL)-1-(2H)-PYRIMIDINYL]-4-FLUORO-N-[[METHYL-(1-METHYLETHYL)-AMINO]SULPHONYL]BENZAMIDE BASF SE (DE) 2008-04-17 WO disclosed
EP-1692115-B1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AG (DE) 2007-12-19 EP disclosed
US-20060293520-A1 Mehtod for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils BASF AKTIENGESELLSCHAFT (DE) 2006-12-28 US disclosed
EP-1692115-A1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2006-08-23 EP disclosed
US-20060004220-A1 Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their Preparation BASF AKTIENGESELLSCHAFT (DE) 2006-01-05 US disclosed
EP-1560810-A1 BIFUNCTIONAL PHENYLISO(THIO)CYANATES; METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF BASF AKTIENGESELLSCHAFT (DE) 2005-08-10 EP disclosed
WO-2005054208-A1 METHOD FOR PRODUCING 3-PHENYL(THIO)URACILS AND 3-PHENYLDITHIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2005-06-16 WO disclosed
WO-2004039768-A1 BIFUNCTIONAL PHENYLISO(THIO)CYANATES; METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF BASF AKTIENGESELLSCHAFT (DE) 2004-05-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293520-A1 Mehtod for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils HPRT1, TH, METTL3 SCN9A 2711/4885POLB 2308/4885APEX1 368/4885
US-20120271049-A1 BIFUNCTIONAL PHENYL ISO (THIO) CYANATES, PROCESSES AND INTERMEDIATES PRODUCTS FOR THEIR PREPARATION TST, IDO1, TMT1A SCN9A 3631/4885POLB 1336/4885APEX1 50/4885
US-20060004220-A1 Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their Preparation TST, TMT1A, IDO1 SCN9A 3755/4885POLB 1447/4885APEX1 38/4885
US-20100035905-A1 Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide DHX15, DHX35, BROX SCN9A 1123/4885POLB 1622/4885APEX1 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.